Allied Academics invites all the participants from all over the world to attend 4th International Conference on Neurology and Neuroimmunology from September 18-20, 2017, Dallas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).
The scientific sessions of Neuroinfection 2017 will focus on the current research going areas including Neurology, Neuroinfectious disorders, Neuroimmune interactions, and its wide therapeutic aspects. Hundreds of millions of people worldwide are affected by neuroimmunological disorders. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as frontotemporal dementia. It is estimated that there are 47.5 million people worldwide with dementia with more than 7.5 million new cases per year - Alzheimer's disease is the most common cause of dementia. Also because of stroke more than 6 million people die per year, More than 50 million people have epilepsy over worldwide.
Why to attend???
Neurology and Neuroimmunology has been become a major challenge for human survival. WHO has produced a report in collaboration with several nongovernmental organizations which addresses that the important human health aspects of the following neuroimmunological disorders epilepsy, headache disorders, multiple sclerosis, dementia, neuroimmunological disorders associated with malnutrition, pain associated with neuroimmunological disorders, Parkinson’s disease, stroke, Alzheimer and some traumatic brain injuries.
This conference provides a platform with its well systematic scientific program to the audience which includes discussions, general talks, keynote presentation and poster sessions etc. Interact with members from the worldwide focused on learning about Neurology and Neuroimmunology and their advancement; this is an opportunity to approach the participants from the Neuropharmacology community.
. World Class Speakers and Fresh New Talent from across the Globe in Health Industry
· Packed Schedule: Workshops, Multi-track Conference, Expo area and more...
· To network with your fellow primary care clinicians.
· To empower yourself to fill the void created by the national shortage of neurologists
· To educate yourself on the diagnosis and treatment of neuroinfectious diseases.
· To enhance your ability to treat the growing number of patients affected by these neuroinfectious diseases.
· Neuroimmunology Researchers
· Neuroimmunology Professors
· Research scholar, students, Ph.d scholar
· Medical Colleges and Hospitals
· Neurology community, society and associations
· Business Entrepreneurs
· Training Institutes
· Software developing companies
· Manufacturing Medical Devices Companies
· Data Management Companies
· Pharmaceutical industries and Biotech Company
Track 1. Neurology and their enhancements
Cognitive enhancement is perhaps one of the most intriguing and controversial topics in neuroscience today.The concept of neurology enhancement is built on the premise that effects of cognitive and mood enhancing medications on the suspect predict effects on the healthy. Nowadays the main classes of drugs used as glutamate activators (ampakine), but wakefulness-promoting agents (modafinil) and potential cognitive enhancers include psychostimulants , which are methylphenidate (MPH) and amphetamine are also frequently used. In the field of Pharmacology, substances that enhance the components of the memory systems: glutamate (neuronal excitation), dopamine or norepinephrine helps to improve brain functionality in healthy person beyond their baseline functioning.
Track 2. Neuroinfectious Disorders
Neuroinfectious diseases are diseases of the central and peripheral nervous system. In other words, the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles. Such neurological infections are brain abscesses, neurosyphilis, neuro-HIV, neurocysticercosis and bacterial, viral, parasitic and fungal causing neurologic syndromes such as, encephalitis, myelitis and meningitis. Neurological symptoms may occur due to the infection itself, or due to an immune response.
Track 3: Neuro-immune interaction
In this, we specially focus on neuro-immune interactions which highlight most on-going interesting research aimed at understanding the mutual relationship between the immune and nervous systems. Although neural-immune interactions can often serve to promote healing and recovery against inflammation can also produce remarkable effects in the CNS. Microglia which are the resident immune cells of nervous system, are responsible for initiating neural responses for neuroprotection.
Track 4: Epigenetics of Neuroimmunolgical Disorder
Epigenetic research in the CNS has the ability to find and target novel pathways that regulate disease severance and progression. The epigenetics terminology is mainly used by neurologists to describe the gene expression regulation for long period. Some modifications have done like linked histone modifications, repositioning of nucleosome and covalent modification with DNA for main processes such as memory related, neuronal development and synaptic plasticity, and. This research has fostered a new understanding of addiction and potential treatments for those suffering from this problem.
Track 5: Neuroimmunological infectious diseases
The term neuro-immune disease refers to a group of diseases characterized by acquired deregulation of both the nervous system and the immune system. These neuroimmunological infectious diseases most often follow an inflammatory response and that may cause lifelong disorder and disability. Encephalitis causes inflammation of the brain. Another diseases related to neuro-immune response are such as meningitis, multiple sclerosis, Human T cell leukemia virus I and II, HIV-associated Opportunistic Infections.
Track 6: Clinical Neuroimmunology
Clinical Neuroimmunology: Strokes, Multiple Sclerosis and many Related Disorders provides as a resource for neurologists and physicians take interested in, and dealing with this branch of neurology. The main approach of this branch is to develop neuroprotective treatment approaches and establishing modest examination procedures such as motion analysis, MRI (magnetic resonance imaging) and OCT (optical coherence tomography). This branch provides an introduction to basic reciprocal relation of neurons and immunology and principles of immunotherapy and also serves as a thorough guide to immune-mediated disorders of the central and peripheral nervous system.
Track 7: Autoimmune Neuropathies
Dysfunctioning of the autonomic nervous system is very common in several neurologic disorders. And central nervous system degenerative disorder may cause Dysautonomia. Autonomic dysfunction is a feature of inherited neuropathies. Chronic acquired autonomic neuropathy may also occur in patients with diabetes or amyloidosis. Guillain-Barre syndrome (GBS) is characterized by local inflammation and demyelination of peripheral nerves.
Track 8: Neuropharmacology
Neuropharmacology is on the simply study and understanding of the mechanism of known exogenous and endogenous chemical agents on neurobiological processes in the nervous system. In the neuropharmacology field, individuals work to produces novel drugs to cure neurochemical disorders, and they have to be responsible for evaluating the level of efficiency and overall safety. Neuropharmacology study includes specializations in such areas as drug neurotoxicity, nervous system disorders, neurotransmission, and behavioural pharmacology.
Track 9: Neuroinflammation
Neurodegeneration is a process that occurs in the central nervous system. And the hallmark of neurodegeneration is associating with the loss of neuronal structure and function. Neurodegeneration is observed after viral infection and causes 'neurodegenerative diseases’, generally considered in the elder stage, such as multiple sclerosis, Parkinson's disease and Alzheimer's disease that negatively affect mental and physical functioning. Recent research have identified that the inflammatory process as being closely linked with multiple neurodegenerative pathways, which are associated with memory loss, depression, dementia and stress.
Track 10: Neurovirology
Neuro-virology is the clinical and high-quality basic science studies on the pathogenesis of viral infections and molecular biology of the nervous system. And also contained report on discovery of novel therapeutic strategies using neurotropic viral vectors. Neuro-virology does also consider the non-viral infections that affect the central nervous system. Neuro-virology targeted to the disease-causing viruses the mechanism through which they infect the human brain and nervous system.
Track 11: Blood Brain Barrier
The blood brain barrier (BBB) consists of specific control point called physical barriers, transporters and enzymes which together maintain the extracellular basement membrane of the central nervous system (CNS) with reduced vesicular transport. The ability to cross the blood brain barrier must be considered for drugs administered, but whose target must lies inside the brain. The main constituents of the BBB include extracellular matrix and astrocytes.
Track 12: Antibody mediated disorder
Treatment of antibody mediated autoimmune disorders remains a difficult clinical problem. The combinations of corticosteroids with cytotoxic chemotherapeutic agents, effective, have broad immunosuppressive effects involving phagocytic cells, T and B lymphocyte function. Treatment usually requires the long term use of corticosteroids alone or combined with cytotoxic agents. This lack of specificity, coupled with other systemic effects, may cause considerable toxicity and treatment related morbidity. Patients refractory to standard treatment present an even more complex therapeutic challenge. Therefore, agents that would specifically target B lymphocytes might provide a safer and more effective treatment of the antibody associated autoimmune disorders.
13. Neurorehabilitation & Neural repair
Neurorehabilitation is a process of restoration of memory functionality of people with neurological disorders of the nervous system. This process involves methodologies aimed at removing impairments and disabilities, and ultimately improving quality of life for persons with neurological disorders.Neurorehabilitation include functional areas mobility, dailylives, and cognitive and mental and communicative abilities. Neurorehabilitation aimed at functional restoration and damage reorganization in the nervous system, and facilitate compensatory and adaptive strategies to improve functioning. The practice of rehabilitation involves a survey, highly dependent on the interaction of multiple disciplines and treatment agents.
The scope of nanoneuromedicine has grown rapidly due to the immediate need for biomarkers and therapies for CNS disorders, traumatic, neuropharmacology, psychiatric, developmental, autoimmune neuromuscular junction disorders, neuroinfectious disorders. The recent enhancements of health care using nanotechnologies and nanomedicines range from biomarker discovery including neuroimaging to therapeutic applications for , inflammatory, infectious, and degenerative disorders of the nervous system.
Many neuroinfectious disorders remain unresolved clinical issues. In many cases, drug simply cannot cross the blood brain barrier (BBB) into the nervous system. The advancement of nanomedicines can improve the delivery of active biological molecules for targeted therapy and imaging.